PEKCAN, G. Et Al. 2017. A biosimilar G-CSF filgrastim is as effective as a reference drug, however, it is not as cost effective as it supposed to be. 6th International Congress on Leukemia Lymphoma Myeloma , (Antalya, Turkey), 112.

PEKCAN, G., YÜKSEL, M., ŞAHİN, U., CİVRİZ BOZDAĞ, S., TOPRAK, S. K., TOPÇUOĞLU, P., ... ARSLAN, Ö.(2017). A biosimilar G-CSF filgrastim is as effective as a reference drug, however, it is not as cost effective as it supposed to be . 6th International Congress on Leukemia Lymphoma Myeloma (pp.112). Antalya, Turkey

PEKCAN, GÜLTEKİN Et Al. "A biosimilar G-CSF filgrastim is as effective as a reference drug, however, it is not as cost effective as it supposed to be," 6th International Congress on Leukemia Lymphoma Myeloma, Antalya, Turkey, 2017

PEKCAN, GÜLTEKİN Et Al. "A biosimilar G-CSF filgrastim is as effective as a reference drug, however, it is not as cost effective as it supposed to be." 6th International Congress on Leukemia Lymphoma Myeloma , Antalya, Turkey, pp.112, 2017

PEKCAN, G. Et Al. (2017) . "A biosimilar G-CSF filgrastim is as effective as a reference drug, however, it is not as cost effective as it supposed to be." 6th International Congress on Leukemia Lymphoma Myeloma , Antalya, Turkey, p.112.

@conferencepaper{conferencepaper, author={GÜLTEKİN PEKCAN Et Al. }, title={A biosimilar G-CSF filgrastim is as effective as a reference drug, however, it is not as cost effective as it supposed to be}, congress name={6th International Congress on Leukemia Lymphoma Myeloma}, city={Antalya}, country={Turkey}, year={2017}, pages={112} }